July 28, 2025

 
When hospitals buy physician practices, the cost of care goes up, analysis indicates
A new working paper by the National Bureau of Economic Research (NBER) adds to the body of research showing that hospitals’ ownership of physician practices has increased substantially and indicates the ongoing integration of providers is driving up prices due to diminished competition. 

The authors found that the share of physicians integrated with a hospital increased 71.5% between 2008 and 2016 (from 27.5% to 47.2%). By 2016, nearly half — 47.2% — of private physician practices were owned by a hospital. 

For the cost analyses, they looked specifically at how hospital/OB-GYN physician integration affected costs associated with childbirth admissions, the most common hospital admission for privately insured patients. On average, they noted, both hospital and physician prices increased. 

Two years after a hospital integration event — defined as a large, one-year increase in the share of physicians practicing at the hospital who are integrated with the hospital — hospital prices for labor and delivery increased by 3.3% ($475) and physician prices increased by 15.1% ($502).

The authors attributed the price increases to reduced competition and provided evidence to support this. 

For instance, they found that prices increased by 9% for physician practices that had already been acquired by a hospital when a new acquisition occurred. They said it was unlikely that the already-merged practices had a sudden change in quality or bargaining ability immediately preceding the acquisition of the new practice. 

The researchers also noted that the increase in hospital prices were larger for: acquisitions that limited rival hospitals’ access to physicians; acquisitions in which the hospital or physician practice already commanded significant market power and could use it to negotiate higher prices with insurers; and acquisitions that increased concentration in the physician market. 

The authors concluded that many of the acquisitions they observed were “likely anticompetitive” and harmed both patients and payers “by increasing the cost of care without generating commensurate increases in quality.” 

In a policy brief published by the Tobin Center for Economic Policy at Yale, the same authors who conducted the analysis noted that “there has been virtually no antitrust enforcement against [mergers between hospitals and physician practices] in the health sector at either the federal or state level.” 

One reason is that nearly all of acquisitions have a valuation that falls below Hart-Scott-Rodino merger reporting thresholds. 

The authors also remarked that antitrust enforcement against vertical mergers such as these is “extremely challenging” because the physician industry consists of hundreds of thousands of small practices and regulators do not have the resources to block the thousands of acquisitions that occur each year. 

They suggested policy changes that might limit the anticompetitive effects of such acquisitions and potentially eliminate the financial incentives that encourage them. One would be for Medicare to pay physicians the same rate whether they are independent or employed by a hospital. Another would be for states to require hospitals and physician practices to provide evidence that their merger would be beneficial. 

(A summary of the working paper is available here.)

The American Hospital Association criticized the research, stating that it relied on old data provided in part by UnitedHealthcare, whose parent company is “one of the most aggressive acquirers of physician practices,” Healthcare Dive reported.

The news outlet pointed out that while “UnitedHealth is the largest payer operator of physician practices, hospital ownership of physicians well outpaces that of insurers overall.”

OUR TAKE: An April 2024 report compiled by Avalere Health in partnership with the Physicians Advocacy Institute (PAI) supports the findings of the NBER analysis in terms of physician practice ownership, though it did not examine the effects on costs.

According to the PAI report, the percentage of physicians employed by hospitals or health systems grew from 25.8% in 2012 to 44% at the beginning of 2018. 

The pandemic put more financial pressure on independent physicians, causing even more of them to sell their practices. By the start of 2022, 73.9% of physicians in the U.S. were employed — 52.1% by hospitals and health systems, and 21.8% by other corporate entities such as private equity firms, insurers, and other businesses (Amazon and CVS, for example). 

During 2022 and 2023, an additional 19,100 physicians became employees of hospitals or other corporate entities (a 5.1% increase from the start of 2022), and hospitals and other corporate entities acquired 8,100 additional physician practices (a 6% increase).

Of those totals, hospitals made 2,800 of the acquisitions (a 7.3% increase in the percentage of hospital-owned practices) and hospitals hired 16,300 of the newly employed physicians (a 5.9% increase in the percentage of hospital-employed physicians). 

As of the end of 2023, according to the report, nearly 80% of physicians were employed by hospitals and corporate entities. 

Survey results released by the American Medical Association in May indicated that 42.2% of physicians were working in private practices in 2024, down from 60.1% in 2012. 

By comparison, the share of physicians working in hospital-owned practices was 42.2% in 2024, up from 23.4% in 2012. 

The reason most often cited for selling a practice was inadequate payment rates, followed by the need for better access to costly resources and the need to better manage payers’ regulatory and administrative requirements.
     
 
HCR #186: Tim Affeldt, PharmD, Fairview Health Services
 
Specialty pharmacy is big business. And while PBMs and big pharma dominate the spotlight, health systems are quietly carving out their own advantage. In this episode, John sits down with Tim Affeldt, VP Specialty/Infusion Operations, Fairview Pharmacy Services, to unpack why health systems don’t just belong in specialty pharmacy — they may be uniquely positioned to lead it. From tighter care integration and faster clinical decisions to improved outcomes and patient experience, Dr. Affeldt lays out a clear case: when pharmacists are part of the care team, everyone benefits. Also on YouTube here.
 
What else you need to know
 
Sanofi agreed to pay approximately $1.15 billion up front to acquire Vicebio, a British biotech with an early-stage non-mRNA combination vaccine candidate for respiratory syncytial virus (RSV)and human metapneumovirus (HMPV). Vicebio’s pipeline also includes a preclinical trivalent vaccine candidate that targets parainfluenza virus Type 3 along with RSV and HMPV. The acquisition includes Vicebio’s Molecular Clamp technology, which, Sanofi explained in the announcement, makes it possible to more quickly develop fully liquid combination vaccines that can be stored at standard refrigeration temperatures. Fully liquid vaccines also can be shipped in prefilled syringes, Sanofi noted. The deal, which provides for additional milestone payments of up to $450 million, is expected to close in the fourth quarter if regulators approve it. 

The FDA has initiated a priority review voucher program that offers eligible developers of drugs and biologics a priority option for bringing their products to market. Announced last month, the Commissioner’s National Priority Voucher (CNPV) pilot program reduces the usual 10- to 12-month review time to just a month or two. The program will use “a collaborative tumor board style review process to accelerate approvals for companies aligned with critical U.S. national health policies,” according to a press statement that includes information about the program’s five priorities, eligibility criteria, and the agency’s solicitation of statements of interest. The FDA will select up to five companies to receive vouchers this year under the pilot program and may increase the number of vouchers awarded after the pilot program concludes. More details are available in a separate list of FAQs, and submissions can be made here

A federal judge temporarily blocked parts of Iowa’s new law regulating pharmacy benefit managers, the Des Moines Register reported, but the injunction applies only to plaintiffs in a lawsuit filed last month after the legislation was signed. The plaintiffs, a group of businesses and employer-provided health plans, claim the law violates federal code and the First Amendment by preventing them from favoring some pharmacies over others. The temporary injunction applies only to certain portions of the law — such as a provision requiring PBMs to pay pharmacists a state-affiliated dispensing fee of $10.68 per prescription, a prohibition on PBMs and health plans discriminating against a pharmacy in terms of referrals, reimbursements, or participation if the pharmacy is acting in accordance with state law, and language that restricts cost-sharing differences for mail-order and retail pharmacies. Other provisions can be enforced while the case is being decided.

Humana said it will eliminate about a third of the prior authorizations required for outpatient services by the start of 2026, including PA requirements for diagnostic services across colonoscopies and transthoracic echocardiograms, as well as select CT scans and MRIs. The insurer also said by Jan. 1, 2026, it will provide decisions within a single business day on at least 95% of all complete electronic PA requests. Additionally, Humana will launch a national gold card program next year that will waive certain PA requirements for physicians who meet eligibility requirements, such as having a track record for submitting requests that meet medical criteria. To increase transparency, the company will also begin publicly reporting its PA metrics. The announcement dovetails with a pledge that 53 insurers, including Humana, made last month to implement PA reforms. CMS finalized a rule in January 2024 to streamline the PA process, with most of the rule’s requirements set to take effect next year. The insurers’ pledge to reform their PA processes is in sync with those requirements.  

Henry Ford Health and Michigan State University launched an initiative called the Innovation Hub that is designed to bring innovative new health care technologies to the market more quickly. The intent is to “narrow the gap between academic innovation and clinical implementation to grow early-stage companies that revolutionize care delivery, broaden health care access, and enhance patient experiences,” according to a July 23 press release. The principal components of the Innovation Hub are clinical expertise, entrepreneurial support, and venture investment. As the founding members, Henry Ford Health, Michigan State University, and MSU Research Foundation will provide $10 million in capital over roughly the next five years to support early-stage companies, including those involved in advancing digital health and artificial intelligence, medical devices and diagnostics, care delivery innovations, and clinical workflow improvement. 

Tim Hingtgen will retire as CEO of Community Health Systems at the end of September. He will also retire as a member of the board but is likely to stay on in a consulting role, according to the announcement. Kevin Hammons, CHS’ president and chief financial officer, will become the interim CEO. Hingtgen has been with CHS for 18 years and became CEO in 2021. Hammons has been with Franklin, Tenn.-based CHS for more than 28 years.   
 
What were reading
 
 
 

Darwin Research Group provides advanced market intelligence and customer insights to health care executives. Our strategic focus is on health care delivery systems and the global shift toward value-based care. Contact John Marchica, CEO and Our Take editor, at jm@darwinresearch.com. Learn more about us here


Copyright © 2025, Darwin Advisory Partners, LLC, d/b/a/ Darwin Research Group. 

8777 N. Gainey Center Drive, Suite 205, Scottsdale, AZ 85258  (480) 923-0802